Marella Thorell
Director, Essa Pharma (United States).
Companies
- Carisma Therapeutics Inc.Board member Jul 1, 2024 to now1
- Seres Therapeutics, Inc.Officer Mar 27, 2024 to now2
- Essa Pharma (United States)Board member Oct 1, 2020 to now3
- Evelo Biosciences, Inc.Chief financial officer Jul 18, 2022 to Nov 8, 20234
- GRI Bio, Inc.Board member Feb 9, 2021 to Dec 15, 20225
- Centessa Pharmaceuticals plcChief Accounting Officer May 27, 2021 to Mar 23, 20226
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GRI Bio, Inc. GRI9,506 shares7$14.1K at $1.48Dec 13, 2022
- Essa Pharma (United States)0 shares8Oct 9, 2025
- Evelo Biosciences, Inc.22,259 shares9Nov 8, 2023
- Centessa Pharmaceuticals plc53,101 shares10Mar 21, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 9, 2025Returned to company 2,881 shares of Essa Pharma (United States)8
- Nov 8, 2023Sold 1,811 shares at $0.33 of Evelo Biosciences, Inc.9
- Nov 7, 2023Exercised options 6,500 shares of Evelo Biosciences, Inc.9
- Nov 2, 2023Sold 3,999 shares at $0.33 of Evelo Biosciences, Inc.11
- Nov 1, 2023Exercised options 12,500 shares of Evelo Biosciences, Inc.11
- Aug 8, 2023Sold 2,004 shares at $9.51 of Evelo Biosciences, Inc.12
- Aug 7, 2023Exercised options 6,500 shares of Evelo Biosciences, Inc.12
- May 8, 2023Sold 38,531 shares at $0.13 of Evelo Biosciences, Inc.13
- May 7, 2023Exercised options 130,000 shares of Evelo Biosciences, Inc.14
- Dec 13, 2022Other 28,517 shares of GRI Bio, Inc.7
- Jul 1, 2022Granted 38,023 shares of GRI Bio, Inc.15
- Mar 21, 2022Other 52,101 shares of Centessa Pharmaceuticals plc10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSeres Therapeutics, Inc., Officer
- 3
- 4
- 5SEC EDGARGRI Bio, Inc., Board member
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Nov 3, 2023
- 12SEC EDGARForm 4 filed Aug 9, 2023
- 13SEC EDGARForm 4 filed May 10, 2023
- 14SEC EDGARForm 4 filed May 9, 2023
- 15SEC EDGARForm 4 filed Jul 6, 2022